return to news
  1. Nephrocare Health Services IPO subscribed 33% so far on Day 2; what we know so far

Market News

Nephrocare Health Services IPO subscribed 33% so far on Day 2; what we know so far

Upstox

3 min read | Updated on December 11, 2025, 15:12 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Nephrocare Health Services IPO: The ₹871.05 crore initial share sale is a fresh issuance of shares aggregating to ₹353.4 crore and an offer for sale (OFS) of ₹517.64 crore by promoters and existing shareholders.

Nephrocare Health Services, known for its brand NephroPlus, will make its stock market debut on December 17. | Image: X/@NephroPlus

Nephrocare Health Services, known for its brand NephroPlus, will make its stock market debut on December 17. | Image: X/@NephroPlus

Nephrocare Health Services IPO: Dialysis services provider Nephrocare Health Services' initial public offering has received 33% subscription so far on the second day of share sale on Thursday, December 11. The issue will conclude on December 12.

Open FREE Demat Account within minutes!
Join now

The ₹871.05 crore IPO attracted bids for 44,20,192 shares against 1,33,87,854 shares on offer, according to the NSE data until 3:10 pm.

The category for retail individual investors (RIIs) received 40% subscription, the portion for non-institutional investors subscribed 18%. The quota for qualified institutional buyers has been booked 30%.

With a price band of ₹438 to ₹460 per share, a lot consists of 32 shares.

The initial share sale is a fresh issuance of shares aggregating to ₹353.4 crore and an offer for sale (OFS) of ₹517.64 crore by promoters and existing shareholders.

The fresh issue proceeds will be used to the tune of ₹129.1 crore for the opening of new dialysis clinics in India, ₹136 crore for repayment of debt and the remainder of funds for general corporate purposes.

Nephrocare Health Services IPO: Allotment and listing date

EventDate
Subscription periodDecember 10 to December 12
Basis of allotmentDecember 15
Initiation of RefundsDecember 16
Credit of Shares to DematDecember 16
Listing dateDecember 17

Nephrocare Health Services IPO GMP

According to investorgain.com and media reports, Nephrocare Health Services' unlisted shares are trading at ₹480 per share, reflecting a grey market premium (GMP) of 4.35% over the upper price band of ₹460.

Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.

About Nephrocare Health Services

Incorporated in 2009, NephroPlus had a global network of 519 clinics, including 51 clinics across the Philippines, Uzbekistan and Nepal, as of September 30, 2025.

In fiscal 2024, it also expanded into the Saudi Arabia market by forming a joint venture with Arabian International Healthcare Holding Company, an Al Faisaliah Group company. Also, its 165-bed dialysis clinic in Tashkent, Uzbekistan, is the largest dialysis clinic globally.

NephroPlus is also the most widely distributed dialysis network in India, with an extensive pan-India network of clinics across 288 cities, spanning across 21 states and 4 union territories, as of September 2025.

With PTI inputs
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story